18F-FAPI PET/CT在成人眶鼻区腺泡状横纹肌肉瘤中的应用:与18F-FDG PET/CT的比较
本文报道1例41岁男性眶鼻区腺泡状横纹肌肉瘤患者,先后行18F-FDG与18FAl-NOTA-FAPI PET/CT。18FAl-NOTA-FAPI PET/CT在原发灶和区域转移淋巴结显示浓密摄取,肿瘤/本底比值优异,而18F-FDG PET/CT仅呈轻至中度摄取;FAPI还检出FDG未识别的骨转移,改变了肿瘤分期和治疗策略。作者认为18FAl-NOTA-FAPI PET/CT在成人眶鼻区腺泡状横纹肌肉瘤评估中可能优于18F-FDG PET/CT。
要点
- 41岁男性眶鼻区腺泡状横纹肌肉瘤,行18F-FDG与18FAl-NOTA-FAPI PET/CT。
- FAPI在原发灶和区域转移淋巴结呈浓密摄取,FDG仅轻至中度摄取。
- FAPI检出FDG未识别的骨转移,改变了分期和治疗策略。
核心结论
- 作者认为18FAl-NOTA-FAPI PET/CT在成人眶鼻区腺泡状横纹肌肉瘤评估中可能优于18F-FDG PET/CT。
研究设计与样本
- 本文为1例41岁男性眶鼻区腺泡状横纹肌肉瘤的病例报告,患者先后接受18F-FDG和18FAl-NOTA-FAPI PET/CT检查。
主要发现
- 18FAl-NOTA-FAPI PET/CT在原发灶和区域转移淋巴结显示浓密摄取,肿瘤/本底比值优异;18F-FDG PET/CT相应病灶仅呈轻至中度摄取。
- 18FAl-NOTA-FAPI PET/CT检出18F-FDG PET/CT未识别的骨转移,改变了患者的肿瘤分期和治疗策略。
临床怎么用
- 作者认为18FAl-NOTA-FAPI PET/CT在成人眶鼻区腺泡状横纹肌肉瘤评估中可能优于18F-FDG PET/CT。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rhabdomyosarcoma is common in children and adolescents but rare in adults. Here, we presented a 41-year-old man with orbital-nasal alveolar rhabdomyosarcoma who underwent both 18 F-FDG and 18 FAl-NOTA-FAPI PET/CT. 18 FAl-NOTA-FAPI PET/CT showed intense uptake in the primary lesion and regional metastatic lymph nodes with an excellent tumor-to-background ratio, compared with the mild to moderate uptake on 18 F-FDG PET/CT. In addition, 18 FAl-NOTA-FAPI PET/CT detected bone metastases that were not identified by 18 F-FDG PET/CT, which altered the patient's tumor stage and treatment strategy. This case suggests that 18 FAl-NOTA-FAPI PET/CT maybe superior to 18 F-FDG PET/CT in the assessment of adult orbital-nasal alveolar rhabdomyosarcoma.
引用
- Li H, Suo L, Zhou J, et al. 18 F-FAPI PET/CT in An Adult Orbital-Nasal Alveolar Rhabdomyosarcoma: Comparisons With 18 F-FDG PET/CT. Clin Nucl Med. 2025. PMID: 40494377. doi:10.1097/RLU.0000000000005943
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。